Form 4: Recursion Pharmaceuticals President and COO Tina Marriott Reports Tax-Related Stock Disposal

Sentiment:

SEC Form 4


Tina Marriott, President and COO of Recursion Pharmaceuticals, reported the disposal of 14,319 shares of Class A Common Stock to cover tax obligations related to the net settlement of restricted stock units.

Summary

  • On August 15, 2024, Tina Marriott, the President and COO of Recursion Pharmaceuticals, reported a transaction involving Class A Common Stock.
  • The transaction involved the disposal of 14,319 shares at a price of $6.69 per share.
  • These shares were withheld by Recursion Pharmaceuticals to satisfy tax withholding and remittance obligations related to the net settlement of restricted stock units.
  • Following the transaction, Marriott directly owns 521,138 shares of Class A Common Stock.
  • Marriott also holds several stock options with varying exercise prices and expiration dates, including options to purchase 470,000 shares at $1.06, 434,122 shares at $8.55, 159,226 shares at $11.40, 4,784 shares at $11.40, 150,000 shares at $2.48, and 447,917 shares at $10.09.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and does not inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to insider transactions and is a standard part of regulatory compliance for publicly traded companies.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is related to tax obligations and does not indicate a change in the executive's long-term outlook on the company.

Key Dates

DateDescription
07/16/2018Annual Vesting Commencement Date for stock options exercisable at $1.06.
12/31/2020Monthly Vesting Commencement Date for stock options exercisable at $2.48.
03/01/2022Vesting date for stock options exercisable at $11.40.
03/01/2023Vesting date for stock options exercisable at $8.55.
03/01/2024Vesting date for stock options exercisable at $10.09.
08/15/2024Date of stock disposal transaction.
07/22/2028Expiration date for stock options exercisable at $1.06.
12/30/2030Expiration date for stock options exercisable at $2.48.
02/04/2032Expiration date for stock options exercisable at $11.40.
02/01/2033Expiration date for stock options exercisable at $8.55.
02/09/2034Expiration date for stock options exercisable at $10.09.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.